针对糖尿病和结核病共患病的宿主导疗法,旨在消除全球结核病
Steven G Smith1, Ruth Bowness2, Jacqueline M Cliff1
1Centre for Inflammation Research and Translational Medicine, Department of Biosciences, Brunel University of London, London, United Kingdom.
概括
宿主导疗法为结核病 (TB) 治疗和预防提供了一种新方法,特别是对于糖尿病患者. 平衡免疫反应对于改善这一群体的结核病结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 结核病 (TB) 控制受到2型糖尿病患病率上升的挑战.
- 糖尿病会加剧结核病相关的炎症,导致治疗结果更差,疾病进展风险增加.
- 在结核病 - 糖尿病并发症中,失调的I型干扰素反应和宿主细胞代谢有助于结果差.
研究的目的:
- 探索宿主导疗法 (HDT) 作为结核病治疗和预防抗生素辅助的潜力.
- 解决结核病糖尿病患者调节免疫反应的复杂问题.
- 突出需要在临床试验中包括结核病和糖尿病并发症,并利用数学建模.
主要方法:
- 审查目前对结核病 - 糖尿病并发症和宿主导治疗的理解.
- 讨论平衡炎症和免疫反应的挑战.
- 强调数学建模在确定治疗点中的作用.
主要成果:
- 高密度治疗旨在减少结核病的免疫病理和组织破坏,特别是在糖尿病患者中.
- 需要仔细调节炎症,以避免阻碍对Mycobacterium结核病的免疫反应.
- 数学建模可以指导个性化治疗策略.
结论:
- 高密度治疗有望改善结核病治疗结果,并预防糖尿病患者的疾病进展.
- 实现平衡的免疫调节是结核病与糖尿病并发症中有效的HDT的关键.
- 将这一群体纳入临床试验和个性化方法对于全球结核病消除至关重要.
相关概念视频
Pulmonary Tuberculosis V
162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
Pulmonary Tuberculosis I
215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III
290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis II
207
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
207
Diabetes: Management and Pharmacotherapy
222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222


